日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia

HQK-1001(一种口服胎儿珠蛋白基因诱导剂)治疗中间型 β-地中海贫血和 HbE/β-地中海贫血的随机 I/II 期试验

Fucharoen, Suthat; Inati, Adlette; Siritanaratku, Noppadol; Thein, Swee L; Wargin, William C; Koussa, Suzanne; Taher, Ali; Chaneim, Nattawara; Boosalis, Michael; Berenson, Ronald; Perrine, Susan P